Literature DB >> 7593469

Natural killing activity is associated with progression of gastric cancer.

K Ono1, Y Imazono, T Misawa, J Nishimura, H Nawata.   

Abstract

Previously, we proposed a new analysis of natural killing activity, in which an individual effector/target cell ratio was employed for comparison according to the peripheral number of effector cells. In 51 patients with gastric cancer, the activity was studied using that modified analysis. Natural killing activity was activated in patients with early cancer, where tumor-cell invasion was restricted to the mucosa or the submucosa, even though in well-differentiated adenocarcinoma with invasion of the mucosa alone, the activity remained at the level of controls. In contrast, the activity in advanced cancer, where tumor cells infiltrated beyond the submucosa, came to be inactivated as the cancer progressed. These facts suggest that natural killing activity in patients with gastric cancer is closely associated with tumor invasion and that reactive activation of the activity against tumor is induced, at least, in some patients with early stage.

Entities:  

Mesh:

Year:  1995        PMID: 7593469     DOI: 10.1007/BF01541092

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  20 in total

1.  Effect of recombinant gamma interferon on natural killer cell activity in patients with gastric cancer.

Authors:  Y Kuwahara; K Kusugami; K Morise; K Shimokata
Journal:  Gastroenterol Jpn       Date:  1987-08

Review 2.  Surgical-stress-related suppression of natural killer cell activity: a possible role in tumor metastasis.

Authors:  R E Pollock; E Lotzová
Journal:  Nat Immun Cell Growth Regul       Date:  1987

3.  Depression of the generation of cell-mediated cytotoxicity by suppressor cells after surgery.

Authors:  S Miyazaki; T Akiyoshi; S Arinaga; F Koba; T Wada; H Tsuji
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

4.  [Observation on natural killer cell activity in gastric cancer patients and effect of nonspecific immunopotentiator administration on its postoperative reduction].

Authors:  H Oshita; S Saji; Y Sugiyama; H Tanemura; K Sakata; S Tanaka; T Ito
Journal:  Nihon Geka Gakkai Zasshi       Date:  1985-10

5.  Role of NK cells in the control of metastatic spread and growth of tumor cells in mice.

Authors:  E Gorelik; R H Wiltrout; K Okumura; S Habu; R B Herberman
Journal:  Int J Cancer       Date:  1982-07-15       Impact factor: 7.396

6.  Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance.

Authors:  G J Bancroft; G R Shellam; J E Chalmer
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

7.  Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity.

Authors:  H F Pross; M G Baines; P Rubin; P Shragge; M S Patterson
Journal:  J Clin Immunol       Date:  1981-01       Impact factor: 8.317

8.  Agranulocytosis caused by ticlopidine and its mechanism.

Authors:  K Ono; K Kurohara; M Yoshihara; Y Shimamoto; M Yamaguchi
Journal:  Am J Hematol       Date:  1991-08       Impact factor: 10.047

9.  Direct evidence for the role of LGL in the inhibition of experimental tumor metastases.

Authors:  T Barlozzari; J Leonhardt; R H Wiltrout; R B Herberman; C W Reynolds
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

10.  Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo.

Authors:  J F Bukowski; J F Warner; G Dennert; R M Welsh
Journal:  J Exp Med       Date:  1985-01-01       Impact factor: 14.307

View more
  3 in total

1.  Clinical significance of natural killing activity in patients with advanced lymphoma.

Authors:  K Ono
Journal:  J Clin Immunol       Date:  1998-03       Impact factor: 8.317

2.  Natural killing activities in chronic liver diseases and hepatocellular carcinoma.

Authors:  K Ono; Y Yamanaga; K Yamamoto; S I Koga; J Nishimura; H Nawata
Journal:  J Clin Immunol       Date:  1996-01       Impact factor: 8.317

3.  Natural killing activity in patients with spontaneous regression of malignant lymphoma.

Authors:  K Ono; M Kikuchi; N Funai; M Matsuzaki; Y Shimamoto
Journal:  J Clin Immunol       Date:  1996-11       Impact factor: 8.317

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.